# Grindeks Kalceks Deutschland GmbH

Company profile · SME (from the award notice)

- Legal form: GmbH
- Seat: Kleve, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 September 2024.

## Identifiers

- Register entry: HRB 19530

As the covered sources state them.

## Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
| --- | ---: | ---: | ---: | ---: | --- | --- |
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | — | 1 | 0 | 1 September 2024 | 1 September 2024 |

Based on the notices and sources Inteliwert covers; not a complete record.

### Awards

- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Lidocain, ATC N01BB02 für die Zeit 01.09.2024 - 31.08.2026](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum)  
  Buyer: DAK-Gesundheit · Awarded: 1 September 2024 · CPV 33600000

## Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

## Website and LinkedIn

Not found in the indexed notices.

## Open tenders that might fit

*Possible match based on public information*

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

- [Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff ab dem 01.10.2026](https://inteliwert.com/tender/opp_18XHM40HRSJQ233B64FWXANJ1R/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130-a-abs-8-sgb-v-mit-dem-w)  
  Open · SME (from the award notice) · New to public tenders · Buyer: GWQ ServicePlus AG · Deadline: 10 May 2028, 10:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f0f0ad06-3f17-412c-9106-71d28765bbb2), Last checked 8 Nov 2026, 09:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Open-House-Rabattverträge 2026-21 Lisdexamfetamin (90 St.)](https://inteliwert.com/tender/opp_5V97787MV6AN17BB79FJWVV6FY/open-house-rabattvertraege-2026-21-lisdexamfetamin-90-st)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Mar 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/11d66e3b-2f29-4ea1-8371-be1eb4a372e6), Last checked 4 Nov 2026, 13:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Open house Arzneimittelrabattverträge zum Wirkstoff Dimethylfumarat, ATC L04AX07](https://inteliwert.com/tender/opp_7YFQQXA9N423S2WZ6E41MN4BKJ/open-house-arzneimittelrabattvertraege-zum-wirkstoff-dimethylfumarat-atc-l04ax07)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Deadline: 31 Jan 2027, 23:59 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/789560c2-abe9-4d86-bf75-7afdd46d030c), Last checked 8 Nov 2026, 08:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Open house Arzneimittelrabattverträge zum Wirkstoff Ticagrelor, ATC B01AC24](https://inteliwert.com/tender/opp_MT6SPCP7CF4VZC316YY1S4B88C/open-house-arzneimittelrabattvertraege-zum-wirkstoff-ticagrelor-atc-b01ac24)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Deadline: 31 Mar 2027, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/75608b41-d8cb-4718-b2d4-e46089476bf3), Last checked 8 Nov 2026, 08:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Open house Arzneimittelrabattverträge zum Wirkstoff Oxycodon und Naloxon, ATC N02AA55](https://inteliwert.com/tender/opp_CBZ6HJHP1PK2HPX5AJHMK5A03P/open-house-arzneimittelrabattvertraege-zum-wirkstoff-oxycodon-und-naloxon-atc-n0)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Deadline: 30 Apr 2027, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/0748e23e-3241-452a-b0ab-e52603e43c28), Last checked 8 Nov 2026, 08:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Open house Arzneimittelrabattverträge zum Wirkstoff Axitinib, ATC L01EK01](https://inteliwert.com/tender/opp_CP39Y8RT8RCQEKY6E45XG3P7YB/open-house-arzneimittelrabattvertraege-zum-wirkstoff-axitinib-atc-l01ek01)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse · Deadline: 30 Apr 2027, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/6035b5a9-53e9-48a8-a173-f24f9cf05c09), Last checked 8 Nov 2026, 08:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren](https://inteliwert.com/tender/opp_SH0FBJ2SDH14XGX076PHVW3DG7/arzneimittelrabattvertraege-gem-130a-abs-8-sgb-v-im-rahmen-von-open-house-verfah)  
  Open · SME (from the award notice) · New to public tenders · Buyer: IKK classic · Deadline: 5 Jul 2028, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/90e38bd0-40a2-47b5-b826-d7e01809c1d6), Last checked 8 Nov 2026, 11:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Arzneimittel mit dem Wirkstoff Testosteron (ATC: G03BA03 - in der Darreichungsform Gel)](https://inteliwert.com/tender/opp_Y3JE1HM2W51E4N1BKWCWKE4EBK/arzneimittel-mit-dem-wirkstoff-testosteron-atc-g03ba03-in-der-darreichungsform-g)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Sachsen - Anhalt · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/4d242533-630a-4b44-b613-307f9ff3e20c), Last checked 8 Nov 2026, 15:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Zwei Produktivsysteme für Klinische Chemie und Immunologie Krankenhaus Märkisch-Oderland GmbH](https://inteliwert.com/tender/opp_V8MX4ZN1NKXM6DF09PBWFQRVH5/zwei-produktivsysteme-fuer-klinische-chemie-und-immunologie-krankenhaus-maerkisc)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Krankenhaus Märkisch-Oderland GmbH · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/45ecd609-686a-448c-9ad1-33f4eee77f64), Last checked 8 Nov 2026, 14:31 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
- [Rahmenvereinbarung über Reagenzienleasing für die immunhämatologische Diagnostik](https://inteliwert.com/tender/opp_C8F68P16TPAHA8TFFWTXRZPJEX/rahmenvereinbarung-ueber-reagenzienleasing-fuer-die-immunhaematologische-diagnos)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Labor Berlin - Charité Vivantes GmbH · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/10c5eb36-82fe-47ce-96ab-7ccfa5e631c2), Last checked 8 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-09-01): [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1), checked 8 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_T1SH88KQSZFQ73V2NTXZCM2P4G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026

## Is this your company?

Send corrections, or ask us to remove the profile, to <hello@inteliwert.com>. You can also ask that the company never be tagged on LinkedIn.

## About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

**Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 September 2024.

---

Page: https://inteliwert.com/company/org_4FZ0C96N594PZRKD53D8KM8HP1/grindeks-kalceks-deutschland-gmbh

Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert.

Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.